Skip to main content
Premium Trial:

Request an Annual Quote

Don't Kill the Messenger

It is widely accepted in the US that it would be a bad thing for Iran to build a nuclear bomb — but is it OK to kill their scientists to keep it from happening? Two assassination attempts on Iranian nuclear scientists have been made in the past several days, says Science Not Fiction's Malcolm MacIver, just a short while after hacking attempts on the computers running Iran's centrifuges were also made. The idea of killing scientists to stem the tide of technological advancement isn't recent — the Unabomber targeted scientists in order to carry out his anti-technology philosophy, MacIver says. But no matter what we may think of Iran having the bomb, killing their scientists and engineers isn't an acceptable solution, he adds. Unfortunately, many in the public see scientists as "Dr. Evil" and the portrayal of scientists in popular entertainment doesn't help that image. "The killing of Iran's scientists raises some troubling concerns about how scientists can be scapegoats for a society's discomforts with technological progress, and how narrative fiction can be a lubricant for such a move," MacIver says.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.